Ratnakar Securities Pvt. Ltd.

BHARAT PARENTERALS LTD.

NSE : NABSE : 541096ISIN CODE : INE365Y01019Industry : Pharmaceuticals & DrugsHouse : Private

BSE1139.9539.95 (+3.63 %)

PREV CLOSE ( ) 1100.00

OPEN PRICE ( ) 1100.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1306

TODAY'S LOW / HIGH ( )1085.00 1140.00

52 WK LOW / HIGH ( ) 8021870

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992

Management Info

- Chairman Bharat Desai - Managing Director

Registered Office

Address Survey No. 144 A,Jarod - Samlaya Road,Haripura, Savli,
Vadodara,
Gujarat-391520

Phone 02667 - 251670, 251680, 9909928332

Email info@bplindia.in / cs@bplindia.in

Website www.bplindia.in

Registrars Details

Adroit Corporate Services Pvt Ltd

18-20, 1st floor, Plot No 639,Makwana Road,,Marol, Andheri (East),Mumbai

Listing : BSE

NEWS

05May Bharat Parenteralsâ€™ arm clears USFDA
Bharat Parenteralsâ€™ subsidiary -- Innoxel Lifesciences has successfull..

05May Bharat Parenterals touches the roof on
Bharat Parenterals is locked its upper circuit at Rs. 1037.25, up by 49...

29Jan Bharat Parenterals receives order wort
Bharat Parenterals has received a $27 million (around Rs 232 crore) orde..

29Jan Bharat Parenterals inches up on receiv
Bharat Parenterals is currently trading at Rs. 1275.00, up by 1.00 point..

13Jan Bharat Parenterals informs about confi
Bharat Parenterals has informed that it enclosed Confirmation Certificat..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	22.8000000000001	264.5
Gross Profit	35.5000000000001	363.1
Operating Profit	68.5000000000001	481.5
Net Sales	802.8	3041.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 35008.75 (5.62%)	M.Cap ( in Cr)72438.87
Onesource Specialty (BSE) 2194.45 (9.41%)	M.Cap ( in Cr)23415.17
Glaxosmithkline Phar (BSE) 3457.70 (4.86%)	M.Cap ( in Cr)56395.27
Astrazeneca Pharma I (BSE) 8896.30 (1.81%)	M.Cap ( in Cr)22332.50
Neuland Laboratories (BSE) 12118.80 (1.32%)	M.Cap ( in Cr)15375.21

Shareholding Pattern

	PROMOTERS	67.2%
	NON-INSTITUTION	32.15%
	FI/BANKS/INSURANCE	0.01%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

BHARAT PARENTERALS LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES